Anorra Pharma Private Limited

The drug is prescribed for adults to prevent cardiovascular complications (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or after a myocardial infarction with a high risk of recurrent events. It should be taken concurrently with acetylsalicylic acid.

Dosage form: tablets, film-coated

ATC: B01AC24

The drug is prescribed for adults to prevent cardiovascular complications (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of recurrence. It should be taken concurrently with acetylsalicylic acid.

Dosage form: tablets, film-coated

ATC: B01AC24

The drug is prescribed to adults for the symptomatic treatment of chronic stable angina (in ischemic heart disease and normal sinus rhythm) or for the treatment of chronic heart failure (NYHA class II-IV).

Dosage form: tablets, film-coated

ATC: C01EB17

The drug is prescribed to adults for the symptomatic treatment of chronic stable angina (with normal sinus rhythm and a heart rate of 70 bpm or higher), as well as for the treatment of chronic heart failure NYHA class II-IV.

Dosage form: tablets, film-coated

ATC: C01EB17

The drug is used for the treatment of adults and adolescents (from 12 years of age weighing at least 35 kg) infected with HIV-1, in combination with other antiretroviral agents. It is also indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection through sexual contact in men at risk.

Dosage form: tablets, film-coated

ATC: J05AR17

The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.

Dosage form: tablets, film-coated

ATC: G04BD08

The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.

Dosage form: tablets, film-coated

ATC: G04BD08